settlement
New Jersey Lab, CEO to Pay $13.2M to Settle Allegations of False Claims
RDx Bio and its CEO will pay $10.3 million to the US and $2.9 million to New Jersey to settle charges of receiving kickbacks and ordering unnecessary tests.
Exagen Settles With DOJ on Kickback Allegations
The autoimmune test developer will pay $653,143 to settle charges that it paid doctors inducement fees in exchange for the use of Exagen's laboratory tests.
Genomic Health to Pay $32.5M to Resolve Cancer Test False Claims Allegations by DOJ
The settlement includes the resolution of allegations brought in two separate actions filed against the firm under the whistleblower provisions of the False Claims Act.
Illumina, Ravgen Settle Patent Lawsuit Over NIPTs
The agreement follows settlements that Ravgen has reached with Labcorp, Quest, and PerkinElmer on allegations they infringed Ravgen's patents.
Sema4 Receives Nasdaq Noncompliance Warning, Will Return $42M Under Payor Lawsuit Settlement
The company's stock price had been below $1 per share for 30 trading days prior to the notice, which Sema4 received Dec. 28.